22 results on '"Zanotti, R"'
Search Results
2. Fairness in Home Healthcare: can patient-centered and nurse-centered measures concur to the same goals?
3. Métodos multivariados aplicados ao melhoramento genético do feijoeiro visando ao aumento da tolerância ao estresse osmótico e biofortificação de grãos
4. Diagnostic frameworks and nursing diagnoses: a normative stance
5. Anagrelide in Essential Thrombocythemia: a retrospettive study'
6. Prospective enrollment of patients with chronic lymphocytic leukemia in a regional registry (CLL Veneto): how unselected patients present to our center
7. Features of relapsed disease in lymphocyte predominant Hodgkin's disease patients
8. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts
9. Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features
10. Evaluation of serum levels of soluble interleukin 2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes
11. Anagrelide in essential thrombocythemia: A retrospective analysis of 220 patients
12. Impact of allergic disorders and anaphylaxis in mastocytosis, based on the ECNM database
13. OCCURRENCE OF HODGKIN LYMPHOMA AND NON-HODGKIN LYMPHOMA IN THE SAME PATIENT. CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS IN A SERIES OF 76 CASES
14. Systemic mastocytosis: A muldisciplinary approach [Lamastocitosi sistemica: Un approccio multidiscliplinare]
15. Impact of allergic disorders and anaphylaxis in mastocytosis: Preliminary data from a study of the European Competence Network on Mastocytosis (ECNM) registry
16. The body mass index is an indicator of advanced systemic mastocytosis: preliminary results from a registry project of the European Competence Network on Mastocytosis (ECNM) registry
17. α(p55) and β(p75) chains of the interleukin-2 receptor are expressed by AML blasts
18. Male osteoporosis and hymenoptera venom anaphylaxis,Osteoporosi maschile e anafilassi da imenotteri
19. INCIDENCE AND OUTCOME OF SECONDARY NON HEMATOLOGICAL CANCERS IN ADULT PATIENTS WITH MASTOCYTOSIS
20. Age at disease onset has a major impact on clinical characteristics and course of mastocytosis
21. RECURRENT LOSS OF FUNCTION OF THE SETD2 GENE IN AGGRESSIVE SYSTEMIC MASTOCYTOSIS AND MAST CELL LEUKEMIA
22. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.